Mineralys Therapeutics

mineralys-therapeutics-moves-forward-with-hypertension-drug-filing

Mineralys Therapeutics Moves Forward with Hypertension Drug Filing

Editorial 16 August, 2025

Mineralys Therapeutics, Inc. (Nasdaq: MLYS) has reported a series of significant clinical advancements and...

mineralys-therapeutics-to-release-q2-financial-results-on-august-12

Mineralys Therapeutics to Release Q2 Financial Results on August 12

Editorial 6 August, 2025

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) will announce its financial results for the second quarter...